Clinical Trials Directory

Trials / Completed

CompletedNCT06447259

Drug Burden Index is Associated With Malnutrition in Community-dwelling Dementia Patients

A Rising Drug Burden Index, Not Anticholinergic Burden, is Related With Malnutrition in Community-dwelling Older Adults With Dementia

Status
Completed
Phase
Study type
Observational
Enrollment
415 (actual)
Sponsor
Sultan Keskin Demircan · Other Government
Sex
All
Age
65 Years – 100 Years
Healthy volunteers

Summary

Malnutrition leads to poor clinical outcomes in dementia patients. The investigator aimed to examine the association between drug burden index (DBI) and anticholinergic burden (ACB) scores with nutrition status in community-dwelling older adults with dementia, considering that drugs may contribute malnutrition. A total of 415 outpatients with dementia, evaluated by Mini Nutrition Assessment test and registered drug information, are included in the study. The investigator calculated the DBI as the sum of all sedatives and anticholinergics taken continuously for at least four weeks prior to admission and evaluated the ACB score. Practice Impact: Due to accompanying chronic diseases and symptoms, cholinergic and/or sedative-loaded drugs are often prescribed to dementia patients. In this study, İnvestigators emphasized that in addition to the cholinergic loads of the drugs used, their sedative loads and the drug doses they use are also important. Avoiding prescribing these medications to patients with dementia will protect them from malnutrition and its negative consequences.

Conditions

Timeline

Start date
2023-05-20
Primary completion
2023-10-01
Completion
2023-12-10
First posted
2024-06-07
Last updated
2024-06-07

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06447259. Inclusion in this directory is not an endorsement.